With the new EU drug strategy now adopted, key questions remain about its direction and implementation—especially the balance between public health, human rights, and security. We spoke with Anna Dovbakh, Chair of the Civil Society Forum on Drugs, about what the strategy means in practice and the role of civil society moving forward.
Ganna Dovbakh is the executive director of the Eurasian Harm Reduction Association. You can download the EU Drugs Strategy for 2026-2030 here, and the action plan here.
The interview is also available in podcast format:
Listen to “Strong Military Budget for Europe, but Not at the Cost of Community Health and Safety | An Interview with Ganna Dovbach” on Spreaker.The topics addressed in the interview are:
- EU Drug Strategy Explained
- Real Impact on Member States?
- Civil Society’s Assessment
- Shift Toward Security?
- Cannabis Reform in the EU
- Eastern Europe & Security Focus
- Role of Civil Society
- Military vs Social Spending
- What Should the EU Do Next?
Interview: Péter Sárosi
Video: István Gábor Takács
